nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP3A4—bone cancer	0.833	1	CbGaD
Brompheniramine—CYP2B6—Cisplatin—bone cancer	0.0195	0.367	CbGbCtD
Brompheniramine—CYP2B6—Doxorubicin—bone cancer	0.0131	0.246	CbGbCtD
Brompheniramine—CYP2C9—Cisplatin—bone cancer	0.0103	0.194	CbGbCtD
Brompheniramine—CYP2D6—Doxorubicin—bone cancer	0.00631	0.119	CbGbCtD
Brompheniramine—CYP3A4—Doxorubicin—bone cancer	0.00401	0.0755	CbGbCtD
Brompheniramine—Tolterodine—CYP3A4—bone cancer	0.000533	0.287	CrCbGaD
Brompheniramine—Carbinoxamine—CYP3A4—bone cancer	0.000458	0.246	CrCbGaD
Brompheniramine—Chlorphenamine—CYP3A4—bone cancer	0.000389	0.209	CrCbGaD
Brompheniramine—Orphenadrine—CYP3A4—bone cancer	0.00025	0.134	CrCbGaD
Brompheniramine—Promazine—CYP3A4—bone cancer	0.000228	0.123	CrCbGaD
Brompheniramine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.000136	0.00122	CbGpPWpGaD
Brompheniramine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.000135	0.00121	CbGpPWpGaD
Brompheniramine—KCNH2—Neuronal System—MDM2—bone cancer	0.000134	0.0012	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—SMO—bone cancer	0.000132	0.00118	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—SMO—bone cancer	0.000132	0.00118	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—SMO—bone cancer	0.000131	0.00118	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—SMO—bone cancer	0.00013	0.00117	CbGpPWpGaD
Brompheniramine—CYP2C19—Biological oxidations—GSTP1—bone cancer	0.000128	0.00115	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—CDK4—bone cancer	0.000127	0.00114	CbGpPWpGaD
Brompheniramine—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	0.000126	0.00113	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—GRM4—bone cancer	0.000122	0.0011	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—RGS1—bone cancer	0.000122	0.0011	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—RGS1—bone cancer	0.000122	0.00109	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—GRM4—bone cancer	0.000122	0.00109	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—GRM4—bone cancer	0.000121	0.00109	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—RGS1—bone cancer	0.000121	0.00109	CbGpPWpGaD
Brompheniramine—CHRM4—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.000121	0.00108	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—GRM4—bone cancer	0.00012	0.00108	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—RGS1—bone cancer	0.00012	0.00108	CbGpPWpGaD
Brompheniramine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000119	0.00107	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—NDUFA12—bone cancer	0.000119	0.00107	CbGpPWpGaD
Brompheniramine—CYP2D6—Biological oxidations—GSTP1—bone cancer	0.000118	0.00106	CbGpPWpGaD
Brompheniramine—CYP2C9—Biological oxidations—GSTP1—bone cancer	0.000117	0.00105	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NDUFA12—bone cancer	0.000116	0.00104	CbGpPWpGaD
Brompheniramine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	0.000116	0.00104	CbGpPWpGaD
Brompheniramine—CHRM5—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.000116	0.00104	CbGpPWpGaD
Brompheniramine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	0.000115	0.00103	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—NT5C3A—bone cancer	0.000114	0.00103	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—GRM4—bone cancer	0.000111	0.000995	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—RGS1—bone cancer	0.000111	0.000995	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—GRM4—bone cancer	0.00011	0.000992	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—RGS1—bone cancer	0.00011	0.000992	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—GRM4—bone cancer	0.00011	0.000989	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—RGS1—bone cancer	0.00011	0.000989	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—GRM4—bone cancer	0.000109	0.000979	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—RGS1—bone cancer	0.000109	0.000979	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—GRM1—bone cancer	0.000106	0.00095	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—GRM1—bone cancer	0.000105	0.000947	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—GRM1—bone cancer	0.000105	0.000944	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—GRM1—bone cancer	0.000104	0.000935	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—GNA11—bone cancer	0.000101	0.000905	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NDUFA12—bone cancer	0.000101	0.000903	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—SMO—bone cancer	0.0001	0.000898	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—JUN—bone cancer	9.86e-05	0.000885	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—NT5C3A—bone cancer	9.85e-05	0.000884	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RGS1—bone cancer	9.68e-05	0.000869	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—GRM4—bone cancer	9.68e-05	0.000869	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—GNA11—bone cancer	9.65e-05	0.000867	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—NT5C3A—bone cancer	9.64e-05	0.000866	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—GRM1—bone cancer	9.61e-05	0.000863	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—SMO—bone cancer	9.58e-05	0.00086	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—GRM1—bone cancer	9.58e-05	0.00086	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—GRM1—bone cancer	9.55e-05	0.000857	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—GRM1—bone cancer	9.46e-05	0.000849	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—GRM4—bone cancer	9.27e-05	0.000832	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RGS1—bone cancer	9.27e-05	0.000832	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—GNA11—bone cancer	9.15e-05	0.000822	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—IL3—bone cancer	9.14e-05	0.00082	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NDUFA12—bone cancer	8.98e-05	0.000806	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—GNA11—bone cancer	8.77e-05	0.000787	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—IL3—bone cancer	8.75e-05	0.000786	CbGpPWpGaD
Brompheniramine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	8.63e-05	0.000774	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—GRM1—bone cancer	8.39e-05	0.000753	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—NT5C3A—bone cancer	8.34e-05	0.000748	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL3—bone cancer	8.3e-05	0.000745	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NDUFA12—bone cancer	8.26e-05	0.000741	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NDUFA12—bone cancer	8.19e-05	0.000735	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—JUN—bone cancer	8.15e-05	0.000732	CbGpPWpGaD
Brompheniramine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—bone cancer	8.14e-05	0.000731	CbGpPWpGaD
Brompheniramine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—bone cancer	8.12e-05	0.000729	CbGpPWpGaD
Brompheniramine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	8.04e-05	0.000722	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—GRM1—bone cancer	8.04e-05	0.000721	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL3—bone cancer	7.95e-05	0.000713	CbGpPWpGaD
Brompheniramine—CYP3A4—Biological oxidations—GSTP1—bone cancer	7.7e-05	0.000692	CbGpPWpGaD
Brompheniramine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	7.6e-05	0.000682	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—NT5C3A—bone cancer	7.44e-05	0.000668	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—NT5C3A—bone cancer	6.84e-05	0.000614	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—GNA11—bone cancer	6.82e-05	0.000612	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—GNA11—bone cancer	6.8e-05	0.00061	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—NT5C3A—bone cancer	6.78e-05	0.000609	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—GNA11—bone cancer	6.78e-05	0.000608	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—SMO—bone cancer	6.77e-05	0.000608	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—SMO—bone cancer	6.75e-05	0.000606	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—SMO—bone cancer	6.73e-05	0.000604	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—GNA11—bone cancer	6.71e-05	0.000602	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—SMO—bone cancer	6.66e-05	0.000598	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RGS1—bone cancer	6.55e-05	0.000588	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GRM4—bone cancer	6.55e-05	0.000588	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GRM4—bone cancer	6.53e-05	0.000586	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RGS1—bone cancer	6.53e-05	0.000586	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GRM4—bone cancer	6.51e-05	0.000584	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RGS1—bone cancer	6.51e-05	0.000584	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RGS1—bone cancer	6.44e-05	0.000578	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GRM4—bone cancer	6.44e-05	0.000578	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—GNA11—bone cancer	6.19e-05	0.000556	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL3—bone cancer	6.18e-05	0.000555	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—GNA11—bone cancer	6.17e-05	0.000554	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL3—bone cancer	6.16e-05	0.000553	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—GNA11—bone cancer	6.15e-05	0.000552	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL3—bone cancer	6.14e-05	0.000551	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	6.09e-05	0.000547	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—GNA11—bone cancer	6.09e-05	0.000547	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL3—bone cancer	6.08e-05	0.000546	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	6.07e-05	0.000545	CbGpPWpGaD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	6.05e-05	0.000543	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SMO—bone cancer	5.91e-05	0.000531	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GRM1—bone cancer	5.68e-05	0.00051	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SMO—bone cancer	5.66e-05	0.000508	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GRM1—bone cancer	5.66e-05	0.000508	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GRM1—bone cancer	5.64e-05	0.000506	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL3—bone cancer	5.61e-05	0.000504	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL3—bone cancer	5.6e-05	0.000502	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GRM1—bone cancer	5.59e-05	0.000501	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL3—bone cancer	5.58e-05	0.000501	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL3—bone cancer	5.52e-05	0.000496	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—GNA11—bone cancer	5.41e-05	0.000485	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NDUFA12—bone cancer	5.4e-05	0.000485	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—TP53—bone cancer	5.38e-05	0.000483	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—GNA11—bone cancer	5.18e-05	0.000465	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ATF1—bone cancer	5.03e-05	0.000451	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ENO2—bone cancer	5.01e-05	0.00045	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL3—bone cancer	4.9e-05	0.00044	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ATF1—bone cancer	4.81e-05	0.000432	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL3—bone cancer	4.69e-05	0.000421	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—DHFR—bone cancer	4.65e-05	0.000417	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—NT5C3A—bone cancer	4.47e-05	0.000402	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GNA11—bone cancer	4.35e-05	0.00039	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ENO2—bone cancer	4.31e-05	0.000387	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ENO2—bone cancer	4.22e-05	0.000379	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFBR2—bone cancer	4.19e-05	0.000376	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFBR2—bone cancer	4.02e-05	0.00036	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—DHFR—bone cancer	4e-05	0.000359	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SMO—bone cancer	4e-05	0.000359	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SMO—bone cancer	3.99e-05	0.000358	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SMO—bone cancer	3.97e-05	0.000357	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IGF1R—bone cancer	3.94e-05	0.000354	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CYP3A4—bone cancer	3.94e-05	0.000354	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SMO—bone cancer	3.94e-05	0.000353	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—DHFR—bone cancer	3.92e-05	0.000352	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IGF1R—bone cancer	3.78e-05	0.000339	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GNA11—bone cancer	3.74e-05	0.000336	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GNA11—bone cancer	3.66e-05	0.000329	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GNA11—bone cancer	3.66e-05	0.000328	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ENO2—bone cancer	3.65e-05	0.000328	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GNA11—bone cancer	3.65e-05	0.000327	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GNA11—bone cancer	3.63e-05	0.000326	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GNA11—bone cancer	3.6e-05	0.000323	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ATF1—bone cancer	3.4e-05	0.000305	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CYP3A4—bone cancer	3.39e-05	0.000304	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ATF1—bone cancer	3.39e-05	0.000304	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—DHFR—bone cancer	3.39e-05	0.000304	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ATF1—bone cancer	3.38e-05	0.000303	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GSTP1—bone cancer	3.37e-05	0.000303	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ATF1—bone cancer	3.35e-05	0.0003	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CYP3A4—bone cancer	3.32e-05	0.000298	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL3—bone cancer	3.32e-05	0.000298	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL3—bone cancer	3.31e-05	0.000297	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL3—bone cancer	3.3e-05	0.000296	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL3—bone cancer	3.26e-05	0.000293	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ENO2—bone cancer	3.26e-05	0.000293	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GNA11—bone cancer	3.17e-05	0.000284	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—DHFR—bone cancer	3.02e-05	0.000271	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ENO2—bone cancer	3e-05	0.000269	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ENO2—bone cancer	2.97e-05	0.000267	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GSTP1—bone cancer	2.9e-05	0.00026	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP3A4—bone cancer	2.87e-05	0.000258	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—KIT—bone cancer	2.86e-05	0.000257	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.86e-05	0.000256	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GSTP1—bone cancer	2.84e-05	0.000255	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFBR2—bone cancer	2.84e-05	0.000255	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFBR2—bone cancer	2.83e-05	0.000254	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GNA11—bone cancer	2.83e-05	0.000254	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFBR2—bone cancer	2.82e-05	0.000253	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFBR2—bone cancer	2.79e-05	0.000251	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—DHFR—bone cancer	2.78e-05	0.00025	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—DHFR—bone cancer	2.76e-05	0.000247	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KIT—bone cancer	2.74e-05	0.000246	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—BRAF—bone cancer	2.69e-05	0.000241	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IGF1R—bone cancer	2.67e-05	0.00024	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IGF1R—bone cancer	2.66e-05	0.000239	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IGF1R—bone cancer	2.65e-05	0.000238	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IGF1R—bone cancer	2.63e-05	0.000236	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—EGFR—bone cancer	2.61e-05	0.000234	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GNA11—bone cancer	2.6e-05	0.000233	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GNA11—bone cancer	2.58e-05	0.000231	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—BRAF—bone cancer	2.58e-05	0.000231	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP3A4—bone cancer	2.56e-05	0.00023	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.55e-05	0.000229	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—EGFR—bone cancer	2.5e-05	0.000224	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GSTP1—bone cancer	2.45e-05	0.00022	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP3A4—bone cancer	2.36e-05	0.000212	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP3A4—bone cancer	2.34e-05	0.00021	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.32e-05	0.000209	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MDM2—bone cancer	2.25e-05	0.000202	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GSTP1—bone cancer	2.19e-05	0.000197	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MDM2—bone cancer	2.16e-05	0.000194	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GSTP1—bone cancer	2.02e-05	0.000181	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GSTP1—bone cancer	2e-05	0.000179	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ENO2—bone cancer	1.96e-05	0.000176	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—JUN—bone cancer	1.96e-05	0.000176	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KIT—bone cancer	1.94e-05	0.000174	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KIT—bone cancer	1.93e-05	0.000173	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KIT—bone cancer	1.92e-05	0.000173	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP9—bone cancer	1.91e-05	0.000171	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KIT—bone cancer	1.9e-05	0.000171	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—JUN—bone cancer	1.88e-05	0.000168	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP9—bone cancer	1.82e-05	0.000164	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—BRAF—bone cancer	1.82e-05	0.000163	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—DHFR—bone cancer	1.82e-05	0.000163	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—BRAF—bone cancer	1.81e-05	0.000163	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—BRAF—bone cancer	1.81e-05	0.000162	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—BRAF—bone cancer	1.79e-05	0.000161	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EGFR—bone cancer	1.76e-05	0.000158	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EGFR—bone cancer	1.76e-05	0.000158	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EGFR—bone cancer	1.75e-05	0.000157	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS2—bone cancer	1.75e-05	0.000157	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.74e-05	0.000156	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GNA11—bone cancer	1.7e-05	0.000153	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—bone cancer	1.54e-05	0.000138	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MDM2—bone cancer	1.52e-05	0.000137	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MDM2—bone cancer	1.52e-05	0.000136	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MDM2—bone cancer	1.51e-05	0.000136	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—bone cancer	1.5e-05	0.000135	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MDM2—bone cancer	1.5e-05	0.000135	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—bone cancer	1.47e-05	0.000132	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—bone cancer	1.47e-05	0.000132	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—JUN—bone cancer	1.32e-05	0.000119	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—JUN—bone cancer	1.32e-05	0.000119	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GSTP1—bone cancer	1.32e-05	0.000118	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—JUN—bone cancer	1.32e-05	0.000118	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—JUN—bone cancer	1.3e-05	0.000117	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—bone cancer	1.29e-05	0.000116	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—bone cancer	1.29e-05	0.000116	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—bone cancer	1.28e-05	0.000115	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—bone cancer	1.28e-05	0.000115	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—bone cancer	1.27e-05	0.000114	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—bone cancer	1.27e-05	0.000114	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—bone cancer	1.24e-05	0.000111	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—bone cancer	1.14e-05	0.000102	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—bone cancer	1.04e-05	9.37e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—bone cancer	1.04e-05	9.35e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—bone cancer	1.04e-05	9.32e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—bone cancer	1.04e-05	9.29e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—bone cancer	1.03e-05	9.29e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—bone cancer	1.02e-05	9.2e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—bone cancer	8.75e-06	7.85e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—bone cancer	8.72e-06	7.83e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—bone cancer	8.69e-06	7.8e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—bone cancer	8.61e-06	7.72e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—bone cancer	6.83e-06	6.13e-05	CbGpPWpGaD
